Private equity buy-and-build activity has suffered a heavy blow through the coronavirus pandemic, with activity dropping to a five-year low according to new data from Silverfleet Capital.
Global venture capital investment remains strong despite dealmaking numbers dropping for the sixth consecutive quarter, new research shows, with a trio of $1bn-plus deals from across the globe helping buoy the industry's figures.
Private equity and venture capital investment in the biotech sector has scored its busiest month of the past 12 as markets continue their recovery from March's coronavirus shock.
Posted by Paul A. Gompers (Harvard Business School), Steven N. Kaplan (University of Chicago), and Vladimir Mukharlyamov (Georgetown University), on Monday, October 19, 2020 Editor's Note: Paul A. Gompers is Eugene Holman Professor of Business
European private equity fundraising activity has come roaring back in the third quarter thanks to a slew of big fund closes - but the coronavirus pandemic is forcing many less-established GPs out of the capital
LPs fears over a second wave of the Covid-19 pandemic is the biggest threat to alternative asset fund managers looking to raise new capital, new research shows.
Stockholm's Summa Equity has bought a majority stake in protein production and research specialist Sengenics through its €610m second fund.
US venture capital exit activity has hit its second-highest value ever recorded despite global volatility in recent months due to the coronavirus crisis, new research shows.
Private equity and venture capital fundraising efforts remain at full throttle despite a tightening up of LP commitments to alternatives in the face of the Covid-19 pandemic, new research shows.
Private equity returns suffered a severe drop in the first half of the year as the long-time booming asset class failed to escape the chaos of the coronavirus crisis, new research shows.
The coronavirus pandemic hit returns for leveraged buyouts sharply in the first half of 2020, according to a private equity performance report by eFront.
Posted by Hal S. Scott (Harvard Law School) and John Gulliver (Program on International Financial Systems), on Monday, September 21, 2020 Editor's Note: Hal S. Scott is the Emeritus Nomura Professor of International Financial Systems
Private equity firms are using portfolio company loans to pay themselves dividends at the highest ratio in five years as demand for corporate debt soars amid the coronavirus crisis.
Private equity dealmaking is continuing its steady recovery from April's nadir, reaching one of its highest monthly results of the last 12 months despite ongoing uncertainty amid the coronavirus crisis.
Credit Suisse has hired 11 researchers for Credit Suisse Founder Securities (CSFS), its Chinese joint venture securities house. The new employees are part of the bank’s bigger plan to expand its onshore presence.
European alternatives funds have reached €2tn of assets under management for the first time despite a dampening of activity amid the coronavirus pandemic.
Posted by Will Gornall (University of British Columbia), on Tuesday, September 1, 2020 Editor's Note: Will Gornall is Assistant Professor of Finance at the Sauder School of Business at the University of British Columbia. This post
Posted by Lucian Bebchuk, Kobi Kastiel, and Roberto Tallarita (Harvard Law School), on Tuesday, August 25, 2020 Editor's Note: Lucian Bebchuk is the James Barr Ames Professor of Law, Economics, and Finance and Director of
Venture capital performance remained 'unscathed' in the first quarter of 2020 despite the onset of the coronavirus pandemic, as the industry consolidated what had been an exceptional 2019, new research shows.
Secondaries private equity fund managers have traditionally had a heavy focus on the North America market - but new fundraises are seeing the sector begin to spread its reach, the latest data from Preqin shows.
